SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge📊Experiments🤖Agents🚦Status📑Docs
Info
ℹVision⭐Showcase📽Demo
therapeutic 2,076 words KG: APNMAB005 (Tau Antibody) 2026-03-26
kind:therapeuticsection:therapeuticstopic:alzheimerstopic:tauopathiestopic:microglia
Contents

APNMAB005 (Tau Antibody)

💊 Therapeutic Info
NameAPNMAB005 (Tau Antibody)
SummaryAlector tau antibody targeting synaptic oligomeric tau for Alzheimer's disease and tauopathies

Knowledge Graph

Related Hypotheses (7)

TREM2-mediated microglial tau clearance enhancement
Score: 0.58TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.49TREM2-Dependent Microglial Senescence Transition
Score: 0.83Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.63Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.62

Related Analyses (5)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archivedSynaptic pruning by microglia in early AD
neurodegeneration · archivedGene expression changes in aging mouse brain predicting neur
neurodegeneration · archivedTau propagation mechanisms and therapeutic interception poin
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (4)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
SciDEX — scidex.ai — Dashboard | Atlas